The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.14
Bid: 0.13
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.02 (15.385%)
Open: 0.14
High: 0.14
Low: 0.14
Prev. Close: 0.14
GUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further Investment – First Tin PLC

8 Apr 2022 07:24

RNS Number : 7752H
Gunsynd PLC
08 April 2022
 

Gunsynd plc

 

("Gunsynd" or the "Company")

 

Further Investment - First Tin PLC

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce that it has invested £75,000 in the Initial Public offering of First Tin PLC (LSE:1SN) (formerly Anglo Saxony Mining Limited) ("First Tin"), a tin development and exploration company.

 

The First Tin investment was executed on the following terms:

· subscription for 250,000 ordinary shares at 30 pence per share for a total consideration of £75,000 from the Company's existing cash resources;

· this investment is in addition to the previous investment announced 24 March 2021 whereby Gunsynd acquired 833,333 ordinary shares at 15 pence per share for a total consideration of £125,000; Gunsynd will hold approximately 0.4% of First Tin on admission to trading on the London Stock Exchange Standard Segment ("Admission");

· following this capital raise First Tin will have 265,534,972 shares in issue with a market cap of approximately £80m;

· Gunsynd's investment is a part of a £20m capital raise supported by institutional investors by way of a Placing and Subscription and UK retail investors through the PrimaryBid mobile app; and

· funds will be used for resource expansion drilling, feasibility/mine development studies and land acquisition cost. First Tin's issued ordinary share capital has today been admitted to trading on the London Stock Exchange Standard Segment.

 

About First Tin PLC

On Admission, First Tin will own 100% of two advanced tin projects, one in Germany and one in Australia, and is looking to rapidly move them into production in order to be able to deliver a sustainable answer to the chronic supply shortage currently faced by many industrial users of tin. Immediately following Admission, the First Tin Board intends to commence the process by which it will obtain a dual listing on the ASX in Australia and will also apply to secure a secondary listing in Frankfurt.

 

Given First Tin has operations located in Germany and Australia, its board considers that enabling direct access to the shares in those jurisdictions will be beneficial to share price performance, liquidity and in further expanding its shareholder base.

 

The long term vision of First Tin is to become a leading global tin producer which will supply fully traceable and verifiable tin units into those global industries which have a high requirement for tin.

These industries include the electric vehicle, renewable energy, energy storage, mobile telephony and

semi-conductor sectors which are currently experiencing strong demand growth.

 

In the year ended 31 December 2020, First Tin had no turnover and had total comprehensive income of £179,518.

 

Peter Ruse, a director of Gunsynd, commented: "Gunsynd is pleased to have the opportunity to add to its existing investment by way of the First Tin's Admission. First Tin has an exciting tin development and exploration strategy via its assets in both Western Europe and now Australia. First Tin is committed to the environmentally sensitive development of advanced hard rock tin projects in conflict free, low political risk jurisdictions. We are very excited by the active resource expansion programmes which will be carried out on both projects following the IPO."

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

For further information please contact:

 

Gunsynd plc

Hamish Harris/ Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCGLGDSXDGDGDI
Date   Source Headline
6th Dec 20129:57 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20127:00 amRNSApproval of Opening Position Disclosure
5th Dec 201211:11 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 201211:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Dec 201212:19 pmRNSForm 8.3 - [Evocutis PLC]
3rd Dec 20127:00 amRNSStrategic Review
3rd Dec 20127:00 amRNSFinal Results
23rd Nov 20127:00 amRNSNotice of Results
5th Nov 20127:00 amRNSIssue of Equity
21st Sep 20127:00 amRNSTR-1 Notification of Major Interest in Shares
8th Aug 201212:24 pmRNSUpdate on commencement of dealings
1st Aug 20127:00 amRNSIssue of Equity and Grant of Share Options
21st Jun 20127:00 amRNSTrading Update
30th Apr 20127:00 amRNSDirectorate Change
4th Apr 20127:00 amRNSDirectorate Change
22nd Mar 20127:00 amRNSInterim Results
29th Feb 20127:00 amRNSNotification of Results
27th Jan 20127:00 amRNSEvocutis validates anti-ageing LabSkinT model
24th Jan 20121:35 pmRNSResult of AGM
13th Jan 20127:00 amRNSEvocutis Opens State-of-the-art laboratory
23rd Dec 20117:00 amRNSDirector/PDMR Shareholding
15th Dec 20117:00 amRNSNotice of AGM and Report and Accounts
29th Nov 20117:00 amRNSPreliminary Results
28th Nov 20117:00 amRNSEvocutis launches antimicrobial LabSkinT model
20th Oct 20115:03 pmRNSResult of GM and Change of Name to Evocutis plc
30th Sep 20117:00 amRNSBusiness Update
27th Sep 20117:00 amRNSPosting of Circular and Notice of General Meeting
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.